Adeno-associated virus-based gene therapy for cystinuria

被引:0
|
作者
Liao, Dazhou [1 ]
Yi, Xianyanling [1 ]
Bai, Yunjin [1 ]
Yang, Yang [2 ,3 ,4 ]
Ai, Jianzhong [1 ]
机构
[1] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, 88 South Keyuan Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Ophthalmol, Ke Yuan Rd 4,1,Gao Peng St, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[4] Collaborat Innovat Ctr, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
UPDATE;
D O I
10.1111/bju.16451
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:742 / 744
页数:3
相关论文
共 50 条
  • [21] An Adeno-Associated Virus-Based Gene Replacement Therapy for Type II Gaucher Disease
    Tao, Yezheng
    Ma, Jing
    Ma, Pengjuan
    Lu, Liang
    Zhu, Xi
    Zhao, Xiaoping
    Tian, Shin-Shay
    MOLECULAR THERAPY, 2023, 31 (04) : 432 - 432
  • [22] Adeno-Associated Virus-Based Gene Therapy Delivering Combinations of Two Growth-Associated Genes
    Tomatsu, Shunji
    Rinz, Estera
    Celik, Betul
    Khan, Shaukat
    MOLECULAR THERAPY, 2024, 32 (04) : 26 - 26
  • [23] Proximal Tubule-Targeted Adeno-Associated Virus (AAV) Gene Therapy for Cystinuria
    Peek, Jennifer L.
    Rosales, Alan
    Qi, Julie
    Menshikh, Anna
    Welch, Richard C.
    Bock, Fabian
    Woodard, Lauren Elizabeth
    Asokan, Aravind
    Wilson, Matthew H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Optimizing Adeno-Associated Virus-Based Gene Therapy for the Treatment of Surfactant Protein B Deficiency
    Zielinska, Nicole
    Pei, Yanlong
    Stevens, Brenna A. Y.
    Campbell, Elena S. B.
    Hughes, Madison E.
    Goens, Melanie M.
    Zheng, Dinghai
    Gordon, D. Benjamin
    Srinivas, Raja R.
    Nielsen, Alec A. K.
    Caswell, Jeff L.
    Castro, Luis A.
    Wootton, Sarah K.
    MOLECULAR THERAPY, 2023, 31 (04) : 559 - 559
  • [25] Prequalification of Analytical Test Methods for Determining the Potency of an Adeno-Associated Virus-Based Gene Therapy Product
    Bries, Amanda
    Wasala, Lakmini
    Slechta, Adam
    Dowling, Vickie
    Yount, Wayne
    MOLECULAR THERAPY, 2024, 32 (04) : 715 - 716
  • [26] Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose
    Shubham Maurya
    Pratiksha Sarangi
    Giridhara R. Jayandharan
    Cancer Gene Therapy, 2022, 29 : 1305 - 1306
  • [27] Adeno-associated virus-based gene therapy for hemophilia A and B: a systematic review and meta-analysis
    Deshpande, Saarang R.
    Joseph, Keerthy
    Tong, Jiayi
    Chen, Yong
    Pishko, Allyson
    Cuker, Adam
    BLOOD ADVANCES, 2024, 8 (23) : 5957 - 5974
  • [28] My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
    Carter, Barrie J.
    HUMAN GENE THERAPY, 2020, 31 (9-10) : 494 - 498
  • [29] Adeno-associated virus (AAV)-based gene therapy for glioblastoma
    Xu, Xin
    Chen, Wenli
    Zhu, Wenjun
    Chen, Jing
    Ma, Bin
    Ding, Jianxia
    Wang, Zaichuan
    Li, Yifei
    Wang, Yeming
    Zhang, Xiaochun
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [30] Adeno-Associated Virus Gene Therapy for Hemophilia
    Samelson-Jones, Benjamin J.
    George, Lindsey A.
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 231 - 247